Market Access Growth Spherix launched a dedicated Market Access suite with payer strategy, key account dynamics, and patient services optimization, enabling cross-sell to biopharma clients seeking data-driven access programs.

Oncology Leadership Market Dynamix on PD-1 inhibition and active participation at major conferences signals strong capability in oncology insights, offering clients competitive benchmarking, market sizing, and biosimilar tracking for the PD-1 space.

Nephrology Focus A strategic AKF partnership alongside nephrology-focused research and Patient Chart Dynamix findings creates credibility and a channel to sell nephrology-centric market intelligence and access solutions to sponsors and device makers.

Physician Network Value The Spherix Network specialty physician panel and Patient Chart Dynamix provide access to real-world physicians and charts, enabling clients to recruit sites, validate hypotheses, and gather real-world evidence through a managed research collaboration model.

Growth Opportunity With a diverse therapeutic scope and mid-size scale, Spherix can bundle Market Access, Market Dynamix, and physician network services to upsell to mid-market pharma and biotech companies seeking end-to-end market intelligence and advisory support.